FIM
Fernwood Investment Management Portfolio holdings
AUM
$288M
This Quarter Return
+19.54%
1 Year Return
+33.53%
3 Year Return
+83.32%
5 Year Return
+196.78%
10 Year Return
+650.37%
AUM
$160M
AUM Growth
+$160M
(+16%)
Cap. Flow
+$16.5M
Cap. Flow
% of AUM
10.33%
Top 10 Holdings %
Top 10 Hldgs %
39.05%
Holding
148
New
10
Increased
63
Reduced
28
Closed
10
Top Buys
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$8.48M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$4.24M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$1.86M |
| 4 |
IPG Photonics
IPGP
|
$816K |
| 5 |
iShares Biotechnology ETF
IBB
|
$703K |
Top Sells
| 1 |
iShares MSCI Canada ETF
EWC
|
$726K |
| 2 |
CAB
Cabela's Inc
CAB
|
$591K |
| 3 |
Invesco Senior Loan ETF
BKLN
|
$509K |
| 4 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$502K |
| 5 |
iShares US Utilities ETF
IDU
|
$412K |
Sector Composition
| 1 | Healthcare | 33.04% |
| 2 | Energy | 9.32% |
| 3 | Consumer Staples | 6.79% |
| 4 | Technology | 6.15% |
| 5 | Consumer Discretionary | 6.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
1
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $13M | 8.13% | 418,010 +136,553 | +49% | +$4.24M |
|
|
PTLA
2
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $12.4M | 7.77% | 229,577 -9,300 | -4% | -$502K |
|
|
MYOK
3
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $10.6M | 6.61% | 246,382 +197,989 | +409% | +$8.48M |
|
4
Altria Group
MO
$113B
| $4.39M | 2.75% | 69,244 +3,456 | +5% | +$219K |
|
5
Gilead Sciences
GILD
$140B
| $4.22M | 2.64% | 52,033 +899 | +2% | +$72.8K |
|
6
Meta Platforms (Facebook)
META
$1.86T
| $4.18M | 2.62% | 24,483 +505 | +2% | +$86.3K |
|
7
CVS Health
CVS
$92.8B
| $3.94M | 2.47% | 48,473 -300 | -0.6% | -$24.4K |
|
8
iShares US Consumer Staples ETF
IYK
$1.35B
| $3.61M | 2.26% | 29,892 +302 | +1% | +$36.4K |
|
9
Biogen
BIIB
$19.4B
| $3.1M | 1.94% | 9,900 +100 | +1% | +$31.3K |
|
10
Philip Morris
PM
$260B
| $3M | 1.88% | 27,042 +519 | +2% | +$57.6K |
|
11
Iron Mountain
IRM
$27.3B
| $2.91M | 1.82% | 74,762 -668 | -0.9% | -$26K |
|
12
Johnson & Johnson
JNJ
$427B
| $2.58M | 1.61% | 19,823 -65 | -0.3% | -$8.45K |
|
13
Visa
V
$683B
| $2.42M | 1.51% | 22,967 +1,007 | +5% | +$106K |
|
14
Union Pacific
UNP
$133B
| $2.16M | 1.35% | 18,660 +120 | +0.6% | +$13.9K |
|
15
Weyerhaeuser
WY
$18.7B
| $2.01M | 1.26% | 59,020 +760 | +1% | +$25.9K |
|
16
Exxon Mobil
XOM
$487B
| $1.99M | 1.24% | 24,235 -200 | -0.8% | -$16.4K |
|
17
Apple
AAPL
$3.45T
| $1.97M | 1.23% | 12,773 +787 | +7% | +$121K |
|
18
Vanguard Mega Cap Growth ETF
MGK
$28.9B
| $1.95M | 1.22% | 18,591 +2,243 | +14% | +$235K |
|
19
First Trust North American Energy Infrastructure Fund
EMLP
$3.32B
| $1.9M | 1.19% | 76,515 +4,197 | +6% | +$104K |
|
20
Phillips 66
PSX
$54B
| $1.87M | 1.17% | 20,458 +450 | +2% | +$41.2K |
|
|
21
Agios Pharmaceuticals
AGIO
$2.19B
| $1.86M | 1.16% | +27,850 | New | +$1.86M |
|
22
Yum China
YUMC
$16.4B
| $1.85M | 1.16% | 46,304 +1,700 | +4% | +$68K |
|
23
Golar LNG
GLNG
$4.48B
| $1.83M | 1.14% | 80,850 +2,700 | +3% | +$61K |
|
24
SBA Communications
SBAC
$22B
| $1.8M | 1.13% | 12,500 -700 | -5% | -$101K |
|
|
IMGN
25
DELISTED
Immunogen Inc
IMGN
| $1.69M | 1.06% | 220,500 +2,000 | +0.9% | +$15.3K |
|